This leads to intensified sensations of satiety and appetite control, making it especially beneficial for women in perimenopause who frequently encounter heightened cravings and energy variations
Researchers discovered that all three groups showed a significant decrease in weight, BMI, and waist circumference
current evidence supports long-term use, as weight regain and metabolic deterioration typically occur upon discontinuation
[2] Gastrointestinal adverse effects were predominantly related to nausea, vomiting, diarrhoea, and constipationsymptoms consistent with the known pharmacological effects of GLP-1 receptor agonists on gastric motility
These results further support the notion that CYP8B1 is regulated by T3, which requires hepatic TR
Patients with certain GLP1R or GIPR variants may experience faster GI adaptation, while those with FTO variants may show different appetite-suppression or metabolic profiles